GlassScriptPhysician profile
Harold E Rutila
NPI 1477509610
$11,957.71
in general payments reported to CMS, 2019-2025
36 companies · $862 in 2025
The $862 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,765 · 2020: $340 · 2021: $334 · 2022: $312 · 2023: $577 · 2024: $768 · 2025: $862.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,207.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,336.90 | 2019 | |
| Abbvie INC. | $461.17 | 2021-2025 | Lupron Depot |
| Astellas Pharma US INC | $361.17 | 2019-2025 | Xtandi |
| Pfizer INC. | $337.84 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $227.29 | 2023-2025 | Orgovyx, Gemtesa |
| Boston Scientific Corporation | $222.43 | 2020-2025 | Spaceoar Vue System - 10ml, Rezum Generator |
| Janssen Biotech, INC. | $200.37 | 2019-2025 | Erleada, Akeega |
| Merck Sharp & Dohme LLC | $177.62 | 2020-2025 | Keytruda, Welireg |
| Blue Earth Diagnostics | $154.84 | 2019-2021 | |
| Coloplast Corp | $102.09 | 2020-2025 | Porges Coloplast |
| Medtronic, INC. | $97.70 | 2022-2023 | Interstim |
| Axonics, INC. | $96.85 | 2021-2023 | Axonics, Bulkamid |
| Procept Biorobotics Corporation | $95.18 | 2024 | Aquabeam System |
| Ferring Pharmaceuticals INC. | $93.94 | 2024-2025 | Adstiladrin |
| Dendreon Pharmaceuticals LLC | $82.93 | 2021-2024 | Provenge |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $81.62 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $80.20 | 2024-2025 | |
| Sun Pharmaceutical Industries INC. | $73.21 | 2022-2024 | |
| Urogen Pharma, INC. | $66.36 | 2023-2025 | Jelmyto |
| Myovant Sciences INC. | $62.47 | 2021-2022 | |
| Olympus America INC. | $61.63 | 2019-2025 | Itind System |
| Teleflex LLC | $56.06 | 2024-2025 | Urolift |
| Accord Healthcare, INC. | $47.12 | 2022-2024 | |
| Allergan, INC. | $40.73 | 2019-2020 | |
| Progenics Pharmaceuticals, INC. | $38.57 | 2024-2025 | |
| Clarus Therapeutics INC. | $37.62 | 2021 | |
| Laborie Medical Technologies Corp. | $36.23 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Myriad Genetic Laboratories, INC. | $35.47 | 2022-2024 | Prolaris |
| Tolmar Pharmaceuticals, INC. | $33.39 | 2019-2021 | |
| Tolmar, INC. | $30.51 | 2023 | |
| Verity Pharmaceuticals INC. | $28.71 | 2024-2025 | Trelstar |
| Medtronic USA, INC. | $22.45 | 2020 | |
| Angiodynamics, INC. | $21.27 | 2025 | Nanoknife |
| Agiliti Surgical, INC. | $19.43 | 2023 | Trinity, Sonablate |
| Genzyme Corporation | $18.34 | 2021 | |
| Civco Medical Instruments | $18.00 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harold Rutila listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.